Marginal note:Suspension and revocation
21.93 (1) Subject to the regulations, the Minister may suspend or revoke an advanced therapeutic product licence, in whole or in part, if
(a) the Minister believes that the risks that are associated with the advanced therapeutic product outweigh the benefits;
(b) the Minister believes that the risks associated with the product or any authorized activity are not being adequately managed or controlled;
(c) in the case of a suspension, any prescribed circumstance exists; or
(d) in the case of a revocation, any prescribed circumstance exists.
Marginal note:Suspension without prior notice
(2) If the Minister believes that an immediate suspension is necessary to prevent injury to health, the Minister may suspend an advanced therapeutic product licence, in whole or in part, without prior notice to its holder and regardless of whether any of the circumstances referred to in subsection (1) exists.
- 2019, c. 29, s. 169
Version in force since June 21, 2019